about
Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.Widespread rotavirus H in commercially raised pigs, United States.Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infectionVLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment.Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmissionRotavirus viremia and extraintestinal viral infection in the neonatal rat model.Zoonotic aspects of rotaviruses.Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countriesGenetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.Three-Level Mixed-Effects Logistic Regression Analysis Reveals Complex Epidemiology of Swine Rotaviruses in Diagnostic Samples from North America.Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG)Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in AfricaFull genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains.Rotavirus enterotoxin NSP4 has mucosal adjuvant properties.Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segmentsSafety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects.Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla?Rotavirus disease and vaccination: impact on genotype diversity.Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Review of group A rotavirus strains reported in swine and cattle.The path to an RSV vaccine.Global distribution of group A rotavirus strains in horses: a systematic review.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.Human P[6] Rotaviruses From Sub-Saharan Africa and Southeast Asia Are Closely Related to Those of Human P[4] and P[8] Rotaviruses Circulating Worldwide.Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.Complete molecular genome analyses of equine rotavirus A strains from different continents reveal several novel genotypes and a largely conserved genotype constellation.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.Genomic characterization of a novel group A lamb rotavirus isolated in Zaragoza, Spain.Genetic heterogeneity in the VP7 of group C rotaviruses.Genotypic and epitope characteristics of group A porcine rotavirus strains circulating in Canada.Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicRapid detection and high occurrence of porcine rotavirus A, B, and C by RT-qPCR in diagnostic samples.VP6 genetic diversity, reassortment, intragenic recombination and classification of rotavirus B in American and Japanese pigs.Detection of a porcine-like rotavirus in a child with enteritis in Italy.
P50
Q27472592-9935ED70-06F8-47EE-873F-4ED1BE82755BQ33816428-2C1EC97D-84B2-4DAF-BE50-581269DB0E7DQ34146235-FF7F5F6D-A8B0-4E6B-99A9-023A667613B7Q34326366-1EAA5C12-C341-4BF9-A7EA-13758B93B028Q34329341-C751C8CB-6A4F-4F32-BCF0-3ED592160C29Q34335469-BF6023E7-5447-404C-AC72-ED718C554CDCQ34545989-7AF37C03-72A3-422D-B52A-0CCCEF2F39BAQ34647817-8846A233-01C1-4D60-8A34-323AE05B4F44Q35005253-1F185A2A-9C22-4F7F-8B1E-382BD03F060EQ35194876-A07D386D-EBD3-491D-8F3B-486B027F7D88Q35806976-5589362E-EC1C-4786-88B6-BFFE7AB9E5BFQ36008361-845DC66E-3226-47CF-88F4-7300D0FAE3AEQ36101005-22A356B0-2DE8-4EF0-A516-5911FDFCFFF1Q36123779-3F85CDCF-2C14-4A6A-8A9D-9CA4737DF2C1Q36498111-AA4D2908-E2C5-4DB2-8744-B9E3897B7971Q36873521-A0418B77-1DDC-4114-A3CC-C5E9F455907DQ36915193-D91A6850-B8B6-4A56-ADE6-CC70E2A490F9Q36978380-2054BBC5-A34B-4F81-957D-3A10C16F0D2DQ36978394-B24B27D7-E74B-4938-989E-73A88D6CC015Q37058335-53D9231E-D302-478C-A035-EDA6CD4F8D94Q37127974-8B8B4CF5-1F50-4DC9-8CEA-10AA2D1F07E0Q37648707-CCCB27E3-5343-4C1C-9079-877F893E0595Q37652537-7C654759-4488-4872-89B6-9489C5132D3EQ37857326-1F3BE299-1E13-4AD2-9E0C-8F2529F1AE2CQ38068232-6429B3AB-B2CE-4A96-9777-B3979BEF523EQ38104020-032E2274-4644-4E00-806F-7DB45A32AC9EQ38111139-4EE02416-D15C-436D-A5AB-43B4D2ABACB2Q38133161-26C82FAC-0370-4F0F-9889-ADBE11EE5E88Q38879736-83CEF5A4-6A7D-440A-BF0B-7BDCE6B86B01Q39066570-7207D005-0FFF-4204-AEFF-3506481D61FDQ39511350-D31E8C8E-7C50-4527-829B-B0A9624D3E4CQ39673190-1DD92DCB-DE39-4EE8-84D2-3A8D37D5F316Q39944921-64597AC3-F874-4B38-9923-1327FAA26821Q39956788-0AFA2CB0-705F-4FEA-9659-C61FC90168D5Q40197122-5019685C-BC3A-415E-B927-6A442A06F168Q40247540-ED4F46E4-92AC-4229-92F1-EB8C65F04622Q40397472-0B1FD887-C4BB-48C9-AC7C-A157888ED6AAQ41751458-FCF9C1F5-72E7-43C1-BCC3-BBAD95712B52Q42209708-F5AACAC2-0E53-4D22-BAF0-F2E99E0BC84EQ42265113-5FF69138-4CF0-42D3-A265-B76B513B11EA
P50
name
Max Ciarlet
@en
Max Ciarlet
@nl
type
label
Max Ciarlet
@en
Max Ciarlet
@nl
prefLabel
Max Ciarlet
@en
Max Ciarlet
@nl